Dow Jones

50 872,11

0,17%

DAX

Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.

Accueil
Investir
Actions
Etats-Unis
NASDAQ
Impax Laboratories (MM) (IPXLE)
Impax Laboratories (MM) (IPXLE) Actualités

Impax Laboratories (MM) (IPXLE)

0,00

(0,00%)

À la fermeture: 10 Juin 10:00PM

0,00

( 0,00% )

Après les heures de négociation: -

Outils de qualité professionnelle, pour des investisseurs individuels.

Premium

IMPAX Receives Notice of Delisting from Nasdaq

IMPAX Laboratories, Inc. (NASDAQ:IPXLE) today announced that it has received notification from The Nasdaq Stock Market, Inc. that the Nasdaq...

IMPAX Provides Further Update of Progress in Filing 10-K and 10-Q and Estimates of Results

IMPAX Laboratories, Inc. (NASDAQ:IPXLE) today provided additional information concerning its progress in filing its annual report on Form 10-K for...

IMPAX Laboratories, Inc. Agrees to Sell $75 Million of 3.5% Senior Subordinated Convertible Debentures Due 2012; Proceeds to be

IMPAX Laboratories, Inc. (Nasdaq:IPXLE) today announced that it has entered into a definitive agreement to sell $75 million aggregate principal...

IMPAX to Increase Existing Credit Facility

IMPAX Laboratories, Inc. (Nasdaq:IPXLE) announced today that it received commitments from Wachovia Bank, National Association and Wachovia Capital...

IMPAX Provides Updates on Progress to File 10-K and Related Matters

IMPAX Laboratories, Inc. (NASDAQ:IPXLE) today reported steps taken to complete its financial closing and file its Annual Report on Form 10-K for...

CORRECTING and REPLACING IMPAX Receives FDA Approval for Generic Version of Rimadyl, a Veterinary Product; Fourth Approval in 20

First graph, first sentence of release should read: xxx a generic version of Rimadyl(R) (Carpofen) 25, 75 and 100 mg Caplets (sted xxx a generic...

IMPAX Receives FDA Approval for Generic Version of Rimadyl, a Veterinary Product; Fourth Approval in 2005

IMPAX Laboratories, Inc. (NASDAQ:IPXLE) today announced that the U.S. Food and Drug Administration (FDA) has granted final approval to the...

Forums

Afficher les forums

Aucune Discussion Trouvée

Ajouter une Discussion

State Street SPDR Russel...

NASDAQ

FUINDX

Aerospace & Defense Port...

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

Vous avez déjà un compte? Connexion

Vous n'avez pas de compte ? Inscription

En m'inscrivant, je confirme avoir lu, compris et accepté les Conditions générales d'ADVFN et j'affirme etre un investisseur privé.

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

Impax Laboratories (MM) (IPXLE)

Outils de qualité professionnelle, pour des investisseurs individuels.